Un 62% de las entidades de pacientes coinciden en que la profesionalización de sus organizaciones es uno de los principales retos a los que se enfrentan. Un hecho que impacta, según estas entidades, ...

Εξερευνήστε ευκαιρίες στη Novartis και στη Sandoz παρακάτω. Για επιπλέον ρόλους στη Novartis Gene Therapies (πρώην AveXis) επισκεφτείτε την Αναζήτηση ...

At Novartis, we have a strong commitment to sustainable development. As a global organization, we recognize the opportunity to drive positive social change. We are on a continuous journey to channel ...

Renal / Rare Disease Territory Account Specialist – Miami – Remote Regular (Sales), Full time Innovative Medicines USA +Alternative Locations Field Sales (USA) Jan 15, 2025 ...

Renal / Rare Disease Territory Account Specialist – Pittsburgh, PA – Remote Regular (Sales), Full time Innovative Medicines USA +Alternative Locations Field Sales (USA) jan 15, 2025 Renal / Rare ...

诺华 承 诺 与残障人士共事并 为 他 们 提供合理的便利 设 施。如果您由于健康状况或残障 在招聘 过 程的任何 环 节 需要合理便利 设 施 或者 为 了履行 职 位的基本 职 能 请发 送 电 子 邮 件 ...

Novartis is committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Scottish Medicines Consortium (SMC) has recommended Fabhalta® (iptacopan) as monotherapy for adults with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia and used under the ...